Predictive factors of early relapse in UICC stage I–III colorectal cancer patients after curative resection

HL Tsai, KS Chu, YH Huang, YC Su… - Journal of surgical …, 2009 - Wiley Online Library
Abstract Background and Objectives To predict the clinicopathologic factors for early relapse
of UICC stage I–III colorectal cancer (CRC) patients undergoing curative resection and thus …

Comparison of proportion of elevated carcinoembryonic antigen levels in patients with appendiceal and colorectal adenocarcinoma: a systematic review and meta …

AT Cristaudo, SB Jennings, DL Morris - Anticancer Research, 2022 - ar.iiarjournals.org
Background/Aim: The proportion of patients with liver metastases in patients with
appendiceal versus colorectal adenocarcinomas was 3.1 percent and 24 percent …

Prognostic value of serum tumor antigen CA19-9 after curative resection of colorectal cancer

IJ Park, GS Choi, SH Jun - Anticancer research, 2009 - ar.iiarjournals.org
Background: CA19-9 was evaluated as a prognostic marker for colorectal cancer and
whether it could be helpful in addition to surveillance using CEA was also tested. Materials …

Comparison of the prognostic value of tumour‐and patient‐related factors in patients undergoing potentially curative surgery for colon cancer

CSD Roxburgh, AM Wallace, GK Guthrie… - Colorectal …, 2010 - Wiley Online Library
Aim To comprehensively compare the prognostic value of tumour‐and patient‐related
factors in patients undergoing curative surgery for colon cancer. Method From a database of …

Clinicopathological utility of sialoglycoconjugates in diagnosing and treating colorectal cancer

Y Inagaki, J Gao, P Song, N Kokudo… - World Journal of …, 2014 - pmc.ncbi.nlm.nih.gov
Aberrant expression of glycoconjugates occurs during malignant transformation of cancer
cells. Overexpression of sialoglycoconjugates in particular may play an important role in the …

Comparative analysis of tumor markers and evaluation of their predictive value in patients with colorectal cancer

ZP Liu, LM Li, XL Liu, DX Zhang - Oncology Research and Treatment, 2012 - karger.com
Background: We evaluated the feasibility of CEA/CK20 mRNA and CEA/CA19-9 proteins as
tumor markers for colorectal cancer by detecting tumor-specific mRNAs in circulating tumor …

Colorectal Carcinoma with Extremely Low CA19‐9

YJ Kawamura, A Tokumitsu, J Sasaki… - Gastroenterology …, 2009 - Wiley Online Library
Aim. The aim of this study is to determine the significance of postoperative sequential
measurements of serum CA19‐9 in patients with extremely low serum level. Patients and …

[PDF][PDF] 新辅助化疗对结直肠癌的作用

任峰, 周建**, 刘栋才, 袁联文, 舒国顺, 周家鹏 - **普通外科杂志, 2008 - zpwz.net
目的探讨短程5 FU/CF 方案新辅助化疗对结直肠癌细胞凋亡, 增殖和p53
表达以及术后并发症和预后的影响. 方法分别采用脱氧核糖核苷酸末端转移酶介导的缺口末端 …

Использование сывороточных онкомаркеров в диагностике злокачественных опухолей органов пищеварения

ЕЮ Еремина - Экспериментальная и клиническая …, 2011 - cyberleninka.ru
Использование сывороточных онкомаркеров в диагностике злокачественных опухолей
органов пищеварения – тема научной статьи по клинической медицине читайте …

[PDF][PDF] The study of p53 and CA19-9 prognostic molecular markers in colorectal carcinomas

G Afrem, S Crăiţoiu, C Mărgăritescu… - Rom J Morphol …, 2010 - academia.edu
Immunohistochemistry represents a relatively new identification technique of cellular and
tissular antigens due to an antigen–antibody binding interactions, applied more and more in …